Volker Derdau studied chemistry in Münster and Braunschweig (Germany) and obtained his PhD in 1999 with Prof. Sabine Laschat. He went for a one-year Deutscher Akademischer Austauschdienst (DAAD) funded Post-Doc in Prof. Victor Snieckus group (Kingston, Canada) before he started at Aventis Pharma Germany (today Sanofi) as laboratory head. Today he is Head of Isotope Chemistry in the Integrated Drug Discovery platform (Sanofi, Frankfurt) and Editor-in-Chief of the Journal of Labeled Compounds and Radiopharmaceuticals (Wiley). Volker is author of more than 60 publications and owner of 8 patents. He has co-organized some International Isotope Society (IIS)-Central European Division (CED) workshops, the global IIS-conference in Heidelberg 2012 and is member of the IIS Board of Trustees (BoT) since 2012. In 2017 he was elected president of the IIS-CED chapter and is actual global IIS president in 2021.